TrialPLoS medicine2021

Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.

María Elvira Balcells et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.